Post-transplant patients with COVID-19 associated acute respiratory distress syndrome, a role for Tociluzumab: A case series

COVID-19 is the disease caused by SARS-CoV-2 that portends both a relatively high mortality rate as well as high rate of intensive care admission amongst all age groups; however effective therapy remains poorly characterized. Post-transplant patients are especially high risk and underrepresented in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ladna, M., Villanueva, F.L., Maharrey, P.B., Lascano, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724995/
https://www.ncbi.nlm.nih.gov/pubmed/33318918
http://dx.doi.org/10.1016/j.rmcr.2020.101319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724995/
https://www.ncbi.nlm.nih.gov/pubmed/33318918
http://dx.doi.org/10.1016/j.rmcr.2020.101319

Ejemplares similares